Compare RXRX & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXRX | CTS |
|---|---|---|
| Founded | 2013 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2021 | 1994 |
| Metric | RXRX | CTS |
|---|---|---|
| Price | $3.80 | $63.94 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 14.2M | 254.1K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | 14.79 | ★ 15.87 |
| EPS | N/A | ★ 0.59 |
| Revenue | $74,681,000.00 | ★ $541,318,000.00 |
| Revenue This Year | $12.11 | $5.55 |
| Revenue Next Year | $82.52 | $5.00 |
| P/E Ratio | ★ N/A | $108.82 |
| Revenue Growth | ★ 26.92 | 4.95 |
| 52 Week Low | $2.77 | $36.03 |
| 52 Week High | $7.18 | $65.99 |
| Indicator | RXRX | CTS |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 64.18 |
| Support Level | $2.85 | $54.75 |
| Resistance Level | $3.99 | N/A |
| Average True Range (ATR) | 0.23 | 2.18 |
| MACD | 0.08 | 0.28 |
| Stochastic Oscillator | 90.28 | 80.42 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.